Henretta J, Araneda D, Pittman K, Thomas F
East Carolina University School of Medicine/University Medical Center, Greenville, North Carolina 27858.
Transplant Proc. 1995 Feb;27(1):1303-4.
These studies argue strongly against the widespread use of skin grafts for rejection testing. Primarily vascularized grafts of a clinically grafted organ would seem to be much more relevant to future studies. These results suggest that the elimination of either class I or class II antigens in grafts or techniques to modulate these antigens or reduce the degree of incompatibility of these antigens by tissue typing should be actively pursued for solid organ grafting in the future.
这些研究强烈反对广泛使用皮肤移植进行排斥反应测试。临床上移植器官的主要血管化移植似乎与未来的研究更相关。这些结果表明,对于未来的实体器官移植,应积极寻求消除移植物中的I类或II类抗原,或采用技术调节这些抗原,或通过组织配型降低这些抗原的不相容程度。